These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 24525634)

  • 21. [Affective disorders during pregnancy : Therapy with antidepressants and mood stabilizers].
    Bergemann N; Paulus WE
    Nervenarzt; 2016 Sep; 87(9):955-66. PubMed ID: 27573672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relevance of clinical pharmacokinetics and therapeutic drug monitoring: anticonvulsant mood stabilizers and antipsychotics.
    Janicak PG
    J Clin Psychiatry; 1993 Sep; 54 Suppl():35-41; discussion 55-6. PubMed ID: 8104932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?
    Graham RK; Tavella G; Parker GB
    J Affect Disord; 2018 Mar; 228():216-221. PubMed ID: 29274567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mood stabilizers during breastfeeding: a systematic review of the recent literature.
    Uguz F; Sharma V
    Bipolar Disord; 2016 Jun; 18(4):325-33. PubMed ID: 27297617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
    Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW
    Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bipolar Disorder in Pregnancy and Postpartum: Principles of Management.
    Khan SJ; Fersh ME; Ernst C; Klipstein K; Albertini ES; Lusskin SI
    Curr Psychiatry Rep; 2016 Feb; 18(2):13. PubMed ID: 26781551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism and excretion of mood stabilizers and new anticonvulsants.
    Ketter TA; Frye MA; Corá-Locatelli G; Kimbrell TA; Post RM
    Cell Mol Neurobiol; 1999 Aug; 19(4):511-32. PubMed ID: 10379423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders.
    Post RM; Weiss SR
    CNS Neurosci Ther; 2011 Dec; 17(6):649-60. PubMed ID: 21159150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.
    Pinto OC; Akiskal HS
    J Affect Disord; 1998 Dec; 51(3):333-43. PubMed ID: 10333987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating recurrent affective disorders during and after pregnancy. What can be taken safely?
    Schou M
    Drug Saf; 1998 Feb; 18(2):143-52. PubMed ID: 9512921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quetiapine and drug interactions: evidence from a routine therapeutic drug monitoring service.
    Castberg I; Skogvoll E; Spigset O
    J Clin Psychiatry; 2007 Oct; 68(10):1540-5. PubMed ID: 17960969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.
    Spina E; Pisani F; Perucca E
    Clin Pharmacokinet; 1996 Sep; 31(3):198-214. PubMed ID: 8877250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiepileptic drugs as mood stabilizers: what did we learn from the epileptology?].
    Rajna P
    Ideggyogy Sz; 2008 Sep; 61(9-10):305-16. PubMed ID: 18841650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent pharmacologic advances in antidepressant therapy for the elderly.
    Preskorn SH
    Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective study on therapeutic drug monitoring of mood stabilizers in real-life clinical scenario.
    Abu-Qurain H; Almashhad F; Lucca JM; Abumadini MS
    J Pharm Bioallied Sci; 2020; 12(3):351-355. PubMed ID: 33100796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: an update review.
    Yeh YC; Ouyang WC
    Kaohsiung J Med Sci; 2012 Apr; 28(4):185-93. PubMed ID: 22453066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.